登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：A600845 B900926 证券简称：宝信软件 宝信B 编号：临2025-037 上海宝信软件股份有限公司关于限制性股票计划部分限制性股票回购注销实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 回购注销原因：上海宝信软件股份有限公司（以下简称"宝信软件"、"公司"）第三期限制性股票计划 因2024年业绩考核目标未达成、部分激励对象离职、退休等原因，其持有的部分已授予未解锁的限制性 股票由公司回购注销。 ● 本次注销股份的有关情况 ■ 一、本次限制性股票回购注销的决策与信息披露 二、本次限制性股票回购注销情况 本次合计回购注销898名激励对象持有的已授予未解锁限制性股票13,025,056股，本次回购注销完成后， 剩余股权激励限制性股票13,188,297股。 （一）因公司2024年业绩考核目标未达成回购注销 因公司2024年业绩考核目标未达成，根据第三期A股限制性股票计划"第九章第二条第5款：因公司层面 业绩考核不达标或个人层面绩效考 ...

Group 1: Company Overview - The company operates multiple retail sub-brands, covering 11 cities in Zhejiang Province with over 200 stores, including DTP pharmacies with more than 500 product specifications [1] Group 2: Financial Performance - The company’s cash distribution for 2024 is planned at 200 million CNY, representing 38.06% of the net profit attributable to shareholders [2] - Cumulative cash dividends over the last three accounting years (2022-2024) amount to 423 million CNY, which is 103.39% of the average net profit during this period [2] Group 3: Strategic Acquisitions - The company acquired 100% of Huadong Pharmaceutical for 369.1 million CNY, enhancing its market share and bargaining power in the Zhejiang market [1] Group 4: Risk Management - The company has established a comprehensive credit risk management system to monitor accounts receivable turnover across different regions and customer types [1] Group 5: Employee Incentives - The company has implemented a restricted stock plan for key employees in 2021 and 2022, with performance indicators including net profit growth and return on equity [2]